Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Double-Blind, Placebo Controlled, Parallel Group, International, Multicenter Study of 12 Weeks Treatment With Trafermin 0.01% Spray in Patients With Diabetic Foot Ulcer of Neuropathic Origin

NCT01217476 is registered in ClinicalTrials.gov with Olympus Biotech Corporation as lead sponsor.

NCT NCT01217476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01217476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Double-Blind, Placebo Controlled, Parallel Group, International, Multicenter Study of 12 Weeks Treatment With Trafermin 0.01% Spray in Patients With Diabetic Foot Ulcer of Neuropathic Origin
Lead sponsor
Olympus Biotech Corporation
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2010
Completion date
March 31, 2013
Enrollment
207 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer of neuropathic origin